$33.3 Million is the total value of Foresite Capital Opportunity Management V, LLC's 9 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Pardes Biosciences Inc | $9,671,000 | -39.7% | 5,227,307 | 0.0% | 29.04% | -28.2% | ||
| Theseus Pharmaceuticals, Inc. | $5,564,000 | +4.9% | 959,275 | 0.0% | 16.70% | +25.0% | ||
| GMTX | Gemini Therapeutics, Inc. | $3,994,000 | -2.9% | 2,435,125 | 0.0% | 11.99% | +15.6% | |
| CMPX | Compass Therapeutics, Inc. | $3,544,000 | -14.0% | 1,554,250 | 0.0% | 10.64% | +2.5% | |
| KNTE | Kinnate Biopharma Inc. | $3,485,000 | -5.2% | 291,667 | 0.0% | 10.46% | +12.9% | |
| ACET | Adicet Bio, Inc. | $2,417,000 | -2.6% | 170,000 | 0.0% | 7.26% | +16.0% | |
| QSI | Quantum-Si Incorporated | $1,742,000 | +18.5% | 633,626 | 0.0% | 5.23% | +41.2% | |
| HIMS | Hims & Hers Health, Inc. | $1,710,000 | +23.2% | 306,431 | 0.0% | 5.13% | +46.8% | |
| ENTA | Enanta Pharmaceuticals, Inc. | $1,180,000 | +9.8% | 22,750 | 0.0% | 3.54% | +30.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Pardes Biosciences Inc | 4 | Q3 2022 | 57.4% |
| Theseus Pharmaceuticals, Inc. | 4 | Q3 2022 | 16.7% |
| Gemini Therapeutics, Inc. | 4 | Q3 2022 | 12.0% |
| Quantum-Si Incorporated | 4 | Q3 2022 | 10.5% |
| Kinnate Biopharma Inc. | 4 | Q3 2022 | 10.5% |
| Compass Therapeutics, Inc. | 4 | Q3 2022 | 10.6% |
| Adicet Bio, Inc. | 4 | Q3 2022 | 7.3% |
| Enanta Pharmaceuticals, Inc. | 3 | Q3 2022 | 3.5% |
| Cue Health Inc. | 2 | Q1 2022 | 13.7% |
| Cullinan Oncology, Inc. | 2 | Q1 2022 | 4.8% |
View Foresite Capital Opportunity Management V, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-05 |
| 4 | 2023-08-31 |
| 4 | 2023-07-19 |
| 4 | 2023-05-10 |
| 4 | 2023-04-06 |
| 4 | 2023-02-22 |
| 4 | 2023-01-03 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 3 | 2022-06-13 |
View Foresite Capital Opportunity Management V, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.